Bentham Science Logo
Track your manuscript:


Scopus CiteScore Metrics: 1.83

Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Abstracted/Indexed in




Endorsements

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Forthcoming Special Issues

CANCER EPIGENETICS


Guest Editor(s): Aamir Ahmad
Tentative Publication Date: November, 2017
Submit Abstract via Email Download Description
Special Issues - In-Press
Please visit again after some time to view these Issues.
Published Special Issues

CANCER BIOMARKERS FROM BENCH TO BEDSIDE


Guest Editor(s): BALÁZS GYŐRFFY
Download Description
Authors' Comments
"I would like to express my sincere thanks for the services by Bentham Science.
I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal"

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran)


Current Cancer Drug Targets

,

Volume 19

-

Number 1



Biography   Open Access



Preface   Open Access



Commentary   Open Access

Targeted Nanotechnology from Bench to Bedside

, 19(1): 3 - 4

Konstantinos Sapalidis, Christoforos Kosmidis, Stela Laskou, Athanasios Katsaounis, Stylianos Mantalobas, Ioannis Passos, Nikolaos Michalopoulos, Aikaterini Amaniti, Chrysa Sardeli and Paul Zarogoulidis


DOI: 10.2174/156800961901181204130142


Review Article

Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases

, 19(1): 5 - 16

Oliesia Gonzalez Quiñones Gonzalez Quiñones and Maria Bernadete Riemma Pierre*


DOI: 10.2174/1568009618666180430125201




Review Article



Review Article

Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?

, 19(1): 26 - 40

A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho and C.J. Maia*


DOI: 10.2174/1568009618666180430144441




Systemic Review Article



Research Article



Articles Ahead of Print

Gender Differences in the Antioxidant Response to Oxidative Stress in Experimental Brain Tumors


María Jesús Ramírez-Expósito, María Dolores Mayas, María Pilar Carrera-González and José Manuel Martínez-Martos*


View Abstract View on PubMed


CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK


Caixia Liang, Ningning Zhang, Qiaoyun Tan, Shuxia Liu, Rongrong Luo, Yanrong Wang, Yaunkai Shi* and Xiaohong Han*


View Abstract View on PubMed


The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy


Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*


View Abstract View on PubMed


Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan’s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea


Rongjin Sun, Sumit Basu, Min Zeng, Robin Sunsong, Li Li, Romi Ghose, Wei Wang, Zhongqiu Liu, Ming Hu* and Song Gao*


View Abstract


Bone Invasive Properties of Oral Squamous Cell Carcinoma and its Interactions with Alveolar Bone Cells: An In Vitro Study


Omel Baneen Qallandar , Faeza Ebrahimi, Farhadul Islam, Riajul Wahab, Bin Qiao, Peter Reher, Vinod Gopalan* and Alfred King-yin Lam*


View Abstract View on PubMed


Characterization of YY1 OPB Peptide for its Anticancer Activity


Yige Qi, Ting Yan, Lu Chen, Qiang Zhang, Weishu Wang, Xu Han, Dangdang Li, Jinming Shi and Guangchao Sui*


View Abstract View on PubMed


Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles


Panpan Ma, Xiaoying Si, Qiubing Chen, Lijun Ma, Meili Hou, Zhigang Xu, Yuejun Kang, Jianglin Wang* and Bo Xiao*


View Abstract View on PubMed


Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells


Jia Wei, Ling Ma, Chenglong Li, Christopher R. Pierson, Jonathan L. Finlay and Jiayuh Lin*


View Abstract View on PubMed



Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer


Gang Wang, Jun-Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao* and Xing-Li Fu*


View Abstract View on PubMed


Editor's Choice

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

, 2019; 19(1): 65 - 73

Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari , Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*


DOI: 10.2174/1568009617666170427105417





p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

, 2018; 18(8): 749 - 772

Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra


DOI: 10.2174/1568009617666170623111953



Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention

, 2018; 18(7): 640 - 651

Sadegh Babashah*, Babak Bakhshinejad, Maryam Tahmasebi Birgani, Katayoon Pakravan and William C. Cho*


DOI: 10.2174/1568009617666170623124710



Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells

, 2018; 18(6): 577 - 591

Tiantian Zhang, Dennis H. Kordish, Yogesh R. Suryawanshi, Rob R. Eversole, Steven Kohler, Charles D. Mackenzie and Karim Essani*


DOI: 10.2174/1568009617666170630143931



The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality

, 2018; 18(5): 480 - 498

Sebastiano Bordonaro, Massimiliano Berretta, Antonino Carmelo Tralongo, Silvia Clementi, Brigida Stanzione and Paolo Tralongo*


DOI: 10.2174/1568009617666170209100322



Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

, 2018; 18(4): 347 - 354

Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying* and Yi Ba*


DOI: 10.2174/1568009617666170710120311



Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance

, 2018; 18(3): 295 - 303

Lin-Jie Li , Yi-Long Wang, Lin-Qing Yuan, Wei-Zhong Gu, Kun Zhu, Min Yang, Duo Zhou, Yao Lv, Min-Ju Li, Zheng-Yan Zhao, Jin-Hu Wang* and Xi Chen*


DOI: 10.2174/1568009617666170330105433



Oncolytic Viruses: The Best is Yet to Come

, 2018; 18(2): 109 - 123

Chantal G. Lemay, Brian A. Keller, Robert E. Edge, Masato Abei and John C. Bell*


DOI: 10.2174/1568009617666170206111609



Open Access Articles

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer

, 2019; 19(1): 74 - 80

Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*




Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice

, 2018; 18(9): 905 - 911

Ashish Saxena, Ravinder Tammali, Kota V. Ramana and Satish K. Srivastava*




p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

, 2018; 18(8): 749 - 772

Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra








Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

, 2014; 14(9): 860 - 871

Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu




Pleiotropic Role of HSF1 in Neoplastic Transformation

, 2014; 14(2): 144 - 155

Natalia Vydra, Agnieszka Toma and Wieslawa Widlak






β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid

, 2013; 13(8): 867 - 878

Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga




Signal Transduction in Human Cutaneous Melanoma and Target Drugs

, 2013; 13(8): 843 - 866

Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov




Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia

, 2013; 13(7): 791 - 810

Ilaria Iacobucci, Annalisa Lonetti, Cristina Papayannidis and Giovanni Martinelli




Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy

, 2013; 13(7): 724 - 734

Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta and Tessa L. Holyoake





Most Cited Articles

Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies

, 2016; 16(9): 773-788.

Reza Salarinia, Amirhossein Sahebkar, Mostafa Peyvandi, Hamid Reza Mirzaei, Mahmoud Reza Jaafari, Maryam Matbou Riahi, Hamed Ebrahimnejad, Javid Sadri Nahand, Jamshid Hadjati, Mobina Ostadi Asrami, Sara Fadaei, Rasoul Salehi and Hamed Mirzaei


DOI: 10.2174/1568009616666151207110143




Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

, 2016; 16(9): 755-764.

Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin


DOI: 10.2174/1568009615666151030102250


Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

, 2016; 16(3): 261-274.

Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra


DOI: 10.2174/1568009616666151106120434


Targeting Tumors with Small Molecule Peptides

, 2016; 16(6): 489-508.

Andrew G. Cheetham, Daniel Keith, Pengcheng Zhang, Ran Lin, Hao Su and Honggang Cui


DOI: 10.2174/1568009616666151130214646


Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy

, 2016; 16(2): 136-146.

Nobumichi Ohoka, Norihito Shibata, Takayuki Hattori and Mikihiko Naito


DOI: 10.2174/1568009616666151112122502


Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer

, 2016; 16(2): 110-118.

Yasumichi Inoue, Yuka Itoh, Koichi Sato, Fumihiro Kawasaki, Chihiro Sumita, Takahito Tanaka, Daisuke Morishita and Hidetoshi Hayashi


DOI: 10.2174/1568009616666151112122126


S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

, 2016; 16(5): 455-465.

Zongliang Lu, Rui Zhou, Ya Kong, Jiajia Wang, Wanyuan Xia, Jing Guo, Jie Liu, Hailan Sun, Kai Liu, Jian Yang, Mantian Mi and Hongxia Xu


DOI: 10.2174/1568009616666151207105720



CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

, 2017; 17(5): 423-444.

Dariush Shanehbandi, Jafar Majidi*, Tohid Kazemi*, Behzad Baradaran and Leili Aghebati-Maleki


DOI: 10.2174/1568009617666170109151128





Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

, 2016; 16(8): 669-688.

Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak


DOI: 10.2174/1568009616666160408145623



Most Accessed Articles

Tunneling Nanotubes: A Versatile Target for Cancer Therapy

, 2018; 18(6): 514-521.

Pragyaparamita Sahu, Soumya Ranjan Jena and Luna Samanta*


DOI: 10.2174/1568009618666171129222637






Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

, 2018; 18(9): 857-868.

Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour


DOI: 10.2174/1568009618666180102102311


Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

, 2017; 17(9): 846-857.

Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*


DOI: 10.2174/1568009617666170214104426



Ponatinib: A Review of Efficacy and Safety

, 2018; 18(9): 847-856.

Fulvio Massaro, Matteo Molica and Massimo Breccia*


DOI: 10.2174/1568009617666171002142659




Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science | Privacy Policy